# Thiogenesis Therapeutics, Corp. (TTI.V): MoatMap facts

As of 13 Nov 2026. Research data, not investment advice.

As of 13 Nov 2026, the MoatMap Score for Thiogenesis Therapeutics, Corp. (TTI.V) is 25/100, ranked against 25,000+ stocks in 38 markets (Quality 25, Value 24, Momentum 63, each scored against its sector).

- MoatMap Score: 25/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 25, Value 24, Momentum 63: each a 0-100 percentile within Healthcare.
- Position: #19,862 overall, #1,739 in Healthcare.
- Listing: Canada, VAN; Healthcare / Biotechnology.
- Last close: 0.65 CAD on 12 Nov 2026.
- Insider filings, last 180 days: directors bought USD 108K.

Source: https://moatmap.ai/stock/TTI.V
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker